BeneVir Biopharm
Gaithersburg
About BeneVir Biopharm
BeneVir's immunotherapies for cancer are designed to induce the immune system to rid the body of two types of tumor cells: those currently responsible for cancer and those responsible for tumor recurrence and poor clinical outcomes. This is a unique approach in the emerging field of cancer immunotherapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: M&A
- Last round: Debt Financing (Nov 2017)
- Website: benevirbiopharm.com
- Phone: 6465943703
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/benevir-biopharm-140246 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.